title: [Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside].
abstract: A 74-year-old woman was admitted in October 1988 with anemia and leukocytopenia. Hematologic investigations established a diagnosis of hypoplastic acute leukemia. She received a low dose of cytosine arabinoside (LDAC: 10 mg/m2 every 12 hours) subcutaneously for 21 days and achieved complete remission (CR) one month later. After one course of LDAC of 14 days, she received LDAC of 21 days every 5 to 6 months as maintenance therapy till April 1993. She has been in remission for 6 years. Intensification therapy with LDAC every 5 to 6 months might be useful in maintaining remission for hypoplastic acute leukemia.
authors.affiliation: Department of Hematology and Chemotherapy, Kanagawa Cancer Center.
authors.forename: S
authors.initials: S
authors.lastname: Fujisawa
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
authors.forename: T
authors.initials: T
authors.lastname: Noguchi
authors.forename: A
authors.initials: A
authors.lastname: Maruta
authors.forename: K
authors.initials: K
authors.lastname: Ogawa
authors.forename: R
authors.initials: R
authors.lastname: Sakai
authors.forename: J
authors.initials: J
authors.lastname: Taguchi
authors.forename: N
authors.initials: N
authors.lastname: Tomita
authors.forename: F
authors.initials: F
authors.lastname: Kodama
authors.forename: T
authors.initials: T
authors.lastname: Okubo
mesh_terms: D000368:Aged; D000740:Anemia / Q000150:complications; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007970:Leukopenia / Q000150:complications; D012074:Remission Induction
chemical_list: D003561:Cytarabine